Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from ...

Catalent一直在其他地方扩大其口服固体剂量能力，在美国和欧洲进行了大量投资。值得注意的是，2022年10月，Catalent以4.75亿美元收购了北卡罗来纳州格林维尔一座333,000平方英尺的设施，从而加强了其地位。该设施具备处理高效活性药物成分 (API)的先进能力，并为口服固体剂型提供全面服务。

CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.

合同制造服务提供商Catalent已达成协议，将其位于新泽西州萨默塞特的口服药物开发和小规模制造工厂出售给私人合同药品制造商Ardena。该交易于今日宣布。 这座获得美国食品和药物管理局(FDA)批准的萨默塞特工厂拥有约200名科学家和技术人员。Ardena表示，收购这座工厂将增强其在口服药物商业化生产方面的能力。 Catalent以其灌装完成工作而闻名，包括为制药公司进行注射器和注射笔的无菌灌装 ...

Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in ...

Ghent, Belgium, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the ...

Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to ...

金吾财讯 | Catalent 已同意将其位于新泽西州萨默塞特的口服药物开发和小规模制造工厂出售给私人合同药品制造商 Ardena。 Catalent 为包括丹麦制药巨头诺和诺德的药物 Wegovy 在内的制药商提供合同制造服务并执行灌装工作，涉及注射器和注射笔的无菌灌装和包装。 拥有诺和诺德控股权的投资公司 Novo Holdings 于 2 月份签署了一项价值 165 亿美元的协议收购 Cat ...

Ghent, Belgium, Oct. 14, 2024 (GLOBE NEWSWIRE) — Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands ...